Korean enforcer sanctions drugmaker for anticompetitive rebate scheme
A Korean drugmaker broke competition rules by bribing healthcare professionals with cash and gifts to prescribe patients with its products, the country’s antitrust watchdog has said.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.